Topic: Publication Bias

The FDA approval process for antidepressants is criticized for requiring only two positive studies while allowing companies to hide numerous failed trials through publication bias. Most clinical trials for these drugs last only six to eight weeks, failing to account for the long-term consequences of manipulating brain chemistry. The "serotonin deficiency" theory is described as an unproven hypothesis sold to doctors and the public to justify treating depression like diabetes.

Racial disparities in the legal system are often driven by implicit bias rather than conscious malice. Prosecutors may show more empathy toward defendants who remind them of themselves, such as a white student with access to private drug rehabilitation. Conversely, Black defendants represented by overworked public defenders often face harsher charges because they lack the same socioeconomic resources and perceived relatability.

Nestle explains that scientific bias often occurs in the design of the research question rather than the data collection itself. By asking narrow questions with predictable outcomes, companies ensure favorable results. This tactic is part of the "Tobacco Industry Playbook," which involves casting doubt on harmful research and hiring scientists to provide self-serving criticisms of independent studies.